TB500 Product Attributes: A Complete Breakdown of Key Specs for B2B Peptide Wholesale

For professionals sourcing high-purity research compounds, TB500 (Thymosin Beta-4) remains a market leader due to its regenerative peptide profile. This breakdown compares leading brands by purity parameters (>98% HPLC verified) and lyophilized form stability. A key advantage is its systemic healing mechanism, differentiating it from site-specific peptides. Current market trends show rising demand for research-grade TB500 in athletic recovery studies. Usage protocols typically involve subcutaneous administration, with dosage parameters varying by molecular weight. Qualification requires third-party COA verification and sterile filtration. Procurement tips: prioritize suppliers offering batch-specific mass spectrometry reports and avoid vendors lacking transparent manufacturing origins. For optimal results, cross-reference reconstitution guidelines with peptide stability data.

Understanding TB500: The Systemic Peptide Advantage

TB500, also known as Thymosin Beta-4, is a naturally occurring peptide that plays a critical role in cellular regeneration and tissue repair. Unlike site-specific peptides that target a single area, TB500 operates systemically, meaning it circulates throughout the body to promote healing across multiple tissues. This makes it a preferred compound in research settings focused on recovery, wound healing, and inflammation modulation. For B2B buyers, understanding the molecular structure and purity of TB500 is essential for ensuring consistent research outcomes.

Key Specifications of TB500

• Molecular Weight: 4963.5 Da (Daltons), which influences reconstitution and dosage calculations.
• Purity: ≥98% verified by High-Performance Liquid Chromatography (HPLC).
• Form: Lyophilized powder, typically in sterile vials of 2 mg, 5 mg, or 10 mg.
• Sequence: Ac-Ser-Asp-Lys-Pro-Asp-Met-Ala-Glu-Ile-Glu-Lys-Phe-Asp-Lys-Ser-Lys-Leu-Lys-Lys-Thr-Glu-Thr-Gln-Glu-Lys-Asn-Pro-Leu-Pro-Ser-Lys-Glu-Thr-Ile-Glu-Gln-Glu-Lys-Gln-Ala-Gly-Glu-Ser-COOH.
• Solubility: Soluble in water or sterile saline; avoid vigorous shaking to prevent degradation.
• Storage: Lyophilized at -20°C; reconstituted solution stable for 7-10 days at 2-8°C.

Purity Parameters and HPLC Verification

For B2B peptide wholesale, purity is non-negotiable. TB500 with ≥98% purity ensures minimal impurities that could confound research results. HPLC verification is the gold standard for confirming purity levels. Leading suppliers provide batch-specific HPLC chromatograms, showing a single dominant peak at the retention time corresponding to TB500. Any additional peaks indicate impurities, which can include truncated sequences, oxidation products, or residual solvents. When sourcing TB500, always request the HPLC report and verify the purity percentage against the claimed value.

Table: Comparison of TB500 Purity Across Brands

Note: Always prioritize suppliers offering batch-specific mass spectrometry reports. This confirms the molecular identity of TB500 and ensures no sequence errors or degradation products are present.

Lyophilized Form Stability and Reconstitution

The lyophilized form of TB500 offers excellent stability when stored correctly. Lyophilization removes water, preventing hydrolysis and microbial growth. For B2B buyers, this means longer shelf life and reduced risk of degradation during transport. Key factors affecting stability include:

• Temperature: Store at -20°C for long-term stability; avoid freeze-thaw cycles.
• Light Exposure: Protect from UV light; use amber vials or opaque packaging.
• Humidity: Keep in desiccated conditions; moisture can cause aggregation.

Reconstitution of TB500 should be performed with sterile water or bacteriostatic water. The recommended concentration is 1 mg/mL for subcutaneous administration. After reconstitution, the solution should be clear and colorless. If particles or cloudiness appear, discard the vial. For optimal peptide stability, use the reconstituted solution within 7-10 days and store at 2-8°C.

Systemic Healing Mechanism vs. Site-Specific Peptides

A key advantage of TB500 is its systemic healing mechanism. Unlike site-specific peptides such as BPC-157, which primarily act on gastrointestinal tissues, TB500 influences multiple pathways including:

• Actin Binding: Promotes cytoskeletal reorganization, aiding cell migration and tissue repair.
• Angiogenesis: Stimulates new blood vessel formation, improving oxygen and nutrient delivery to damaged tissues.
• Anti-Inflammatory: Reduces pro-inflammatory cytokines, accelerating recovery.
• Stem Cell Mobilization: Encourages stem cell homing to injury sites.

This systemic action makes TB500 ideal for research on multi-tissue recovery, such as in athletic injury models or chronic wound studies. For B2B buyers, this broad applicability increases the compound’s value across multiple research domains.

Current Market Trends for TB500 in Research

Market trends indicate rising demand for research-grade TB500 in athletic recovery studies. As of 2024, the global peptide therapeutics market is projected to grow at a CAGR of 8.5%, with TB500 being a key driver in the regenerative peptide segment. Researchers are increasingly exploring TB500 for:

• Muscle Recovery: Reducing recovery time after intense exercise or injury.
• Joint Health: Promoting repair of ligaments and tendons.
• Cardiac Repair: Investigating its role in post-ischemic heart recovery.
• Wound Healing: Accelerating closure of chronic wounds and burns.

For B2B wholesalers, this trend means increased demand for high-purity TB500 with documented quality assurance. Suppliers who can provide batch-specific COAs and mass spec reports will have a competitive edge.

Usage Protocols: Dosage and Administration

Usage protocols for TB500 in research settings typically involve subcutaneous administration. Dosage parameters vary by molecular weight and research objectives. Common protocols include:

• Loading Phase: 2.5-5 mg per week, divided into 2-3 doses, for 4-6 weeks.
• Maintenance Phase: 2.5 mg per week, single dose, for ongoing research.
• Acute Injury: 5 mg every 3-4 days for 2-3 weeks.

For B2B buyers, it is crucial to provide clear dosage guidelines to end-users. Always recommend starting with lower doses to assess tolerance and adjust based on research outcomes. Subcutaneous injection sites include the abdomen, thigh, or upper arm. Rotate injection sites to minimize irritation.

Table: TB500 Dosage Guidelines by Research Application

Important: Dosage parameters should be based on molecular weight calculations. For TB500 (4963.5 Da), a 1 mg dose corresponds to approximately 0.2 µmol. Always use sterile filtration (0.22 µm filter) before administration to ensure sterility.

Qualification Requirements for TB500

Qualification of TB500 for research use requires rigorous verification. Key steps include:

• Third-Party COA: Verify purity, identity, and endotoxin levels from an independent lab.
• Mass Spectrometry: Confirm molecular weight and sequence integrity.
• Sterile Filtration: Ensure the product is filtered through a 0.22 µm membrane to remove bacteria and particulates.
• Stability Testing: Assess lyophilized and reconstituted stability under recommended storage conditions.

For B2B buyers, establishing a qualification protocol ensures consistency across batches. Always request documentation from suppliers, including HPLC chromatograms, mass spec reports, and endotoxin assays. Avoid vendors who cannot provide transparent manufacturing origins or batch-specific data.

Procurement Tips for B2B Buyers

When sourcing TB500 for wholesale, prioritize suppliers who demonstrate quality and transparency. Key procurement tips include:

• Batch-Specific Reports: Request HPLC and mass spec reports for each batch. This ensures the TB500 meets purity and identity specifications.
• Manufacturing Origins: Choose suppliers with cGMP-certified facilities. Avoid vendors with unclear or undisclosed manufacturing locations.
• Sterility Assurance: Confirm that the product is sterile-filtered and packaged in a controlled environment.
• Stability Data: Ask for stability studies showing the shelf life of lyophilized TB500 under various conditions.
• Customer Support: Work with suppliers who provide technical support for reconstitution and storage guidelines.

For optimal results, cross-reference reconstitution guidelines with peptide stability data. For example, TB500 reconstituted in sterile water at 1 mg/mL is stable for 7-10 days at 2-8°C. If longer stability is needed, consider using bacteriostatic water, which extends stability to 14-21 days.

Conclusion: Sourcing High-Purity TB500 for Research

TB500 remains a cornerstone in regenerative peptide research due to its systemic healing mechanism and high purity profile. For B2B buyers, understanding key specs such as molecular weight, purity parameters, and lyophilized stability is essential for making informed procurement decisions. Current market trends show rising demand for research-grade TB500 in athletic recovery and wound healing studies. By prioritizing suppliers with batch-specific mass spectrometry reports and transparent manufacturing origins, you can ensure consistent quality and reliable research outcomes. Always verify third-party COA data and follow sterile filtration protocols to maintain peptide integrity. With the right sourcing strategy, TB500 can be a valuable addition to your peptide portfolio.